Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$40.3B
98M shares
52-week range
$282.77 – $426.22
94% from low
Sector
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NYSE
CS
P/S (TTM)
8.8
EV / FCF (TTM)
115
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.
www.waters.comNo one on the platform currently holds WAT.
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2025-09-30 | 1,482 | $444.3K |
No one on the platform has traded WAT yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 21.9% | 31.6% | 30.2% | — | — | — |
| Rev. Growth % | 7.0% | 6.0% | ||||
| Profit Margin % | 20.3% | 22.5% | 20.8% | |||
| Free Cash Flow Margin % | 17.1% | 17.6% | 20.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +3.7% on the P/E track.
At today's price, your expected annual return is +8.6% on the P/E track.
At today's price, your expected annual return is +13.7% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $6.5B | +104.2% | $14.57 | $14.51–$14.62 | 28.6× | 13 |
| 2027 | $7.1B | +10.4% | $16.50 | $16.02–$17.74 | 25.3× | 14 |
| 2028 | $7.5B | +5.9% | $18.39 | $14.67–$22.35 | 22.7× | 5 |
| 2029 | $8.1B | +6.7% | $20.34 | $20.07–$21.13 | 20.5× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $3.01 | $3.05 | +1.3% |
| 2026-05-05 | $2.31 | $2.70 | +16.9% |
| 2026-02-09 | $4.51 | $4.53 | +0.4% |
| 2025-11-04 | $3.21 | $3.40 | +5.9% |
| 2025-08-04 | $2.94 | $2.95 | +0.3% |
| 2025-05-06 | $2.22 | $2.25 | +1.4% |
| 2025-02-12 | $4.03 | $4.10 | +1.7% |
| 2024-11-01 | $2.68 |
| $2.93 |
| +9.3% |
| $24.6B |
| — |
| LHLabcorp Holdings Inc. | $320.14 | +1.53% | $26.3B | — |
| MEDPMedpace Holdings, Inc. | $618.49 | +3.88% | $17.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
AskSlim Market Week - Friday, Sep. 5 $HYG $TSLA $CRWD $WAT $TMO https://talkmarkets.com/article/askslim-market-week---friday-sep-5-1788565471
View on StockTwits ↗
Morgan Stanley analysts view Waters Corporation as the best-positioned life sciences diagnostics company following China’s release of its final pricing framework for clinical laboratory services. The framework covers 662 core items, 114 add-ons and seven extensions, maintaining differentiated treatment for advanced workflows such as mass spectrometry and introducing tiered discounts for multi-test panels. Waters benefits from its exposure to mass spectrometry and complex microbiology workflows, which retain premium treatment under the new rules. Morgan Stanley called the framework constructive for both clinical mass spectrometry and microbiology, while Waters said preserved surcharges should support adoption by recognizing the clinical value of quantitative testing. For Danaher, the framework largely matches management’s prior expectations. Routine chemistry and immunoassays face standardized pricing and pressure on hospital lab economics. $WAT
View on StockTwits ↗
$WAT Healthcare company that hasn't really been looked at. I'm in for 50 shares!
View on StockTwits ↗
$WAT this monthly is looking pretttty. Outsized move incoming.
View on StockTwits ↗
$WAT printed a new 52-week high today
View on StockTwits ↗
$WAT undiscovered breakout with 772 watchers
View on StockTwits ↗
$WAT | Waters Corp. (Healthcare / Life Sciences Tools 📢) $WAT is pushing directly into all-time high resistance around $415.00–$421.74 after breaking out off the $357.00 volume shelf. The 1W chart shows heavy volume profile acceptance holding as price coils tightly under its macro range boundary. Key Technical Levels: • Confirmation Trigger: $421.75 🚀 • Pivot Support: $400.00 🐂 • Overhead Target 1: $435.00 🎯 • Overhead Target 2: $450.00 💰 • Downside Risk Level: $357.00 🐻 • Stop Loss: $388.00 🔴 Flow & Market Bias: Structure: 1W Range Compression / ATH Resistance Test Bias: Bullish above $400.00 #WAT #optionsflow #stockmarket #technicalanalysis #swingtrading #hovdid
View on StockTwits ↗$WAT printed a new 52-week high today
View on StockTwits ↗
$MSCI $IQV $IBKR $WAT $HMC MSCI benefits from investment indexes and analytics demand, IQVIA benefits from pharmaceutical research and clinical-trial activity, Interactive Brokers benefits from trading and client-asset growth, Waters benefits from analytical and laboratory equipment demand, and Honda benefits from global vehicle demand. I'm watching asset flows, clinical spending, trading volumes, lab demand, and auto sales.
View on StockTwits ↗$WAT printed a new 52-week high today
View on StockTwits ↗BDX: A Dividend King In The Medical Supply Business $BDX Also Mentions: $WAT https://talkmarkets.com/article/bdx-a-dividend-king-in-the-medical-supply-business-1786430481
View on StockTwits ↗
$WAT Opportunity Citigroup raises target price to $470 from $425
View on StockTwits ↗
$WAT $ROP $FMX $ADM $HIG Waters leads analytical instruments, Roper Technologies expands software solutions, FEMSA strengthens consumer businesses, ADM benefits from global agricultural demand, and Hartford Financial delivers stable insurance earnings.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.